Risk of skin reactions when using ibuprofen-based medicines

Bibliography

• WARNER TD, MITCHELL JA: Cyclooxygenase-3 (COX-3): Filling in the gap towards a COX continuum? Proc. Natl. Acad. Sci. USA (2002) 99(21):13371–13373.
   PubMed Web of Science ®Google Scholar
• LAUNEVILLE 0, BREWER DK, DE WITT DL: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. I Pharm. Exp. Then (1994) 271:927–934.
   PubMed Web of Science ®Google Scholar
• SPILVA A, MUKTANS Y: Gina de las especialidades farmaceuticas. XXVIIIth edition, Caracas 2004/2005.
   Google Scholar
• IMS HEALTH MAT, January 2005.
   Google Scholar
• LAZAROU J, POMERANZ BH, COREY PN: Incidence of adverse drug reactions in hospitalizad patients. A meta-analysis of prospective studies. J. Am. Med. Assoc. (1998) 279(15):1200–1205.
   PubMed Web of Science ®Google Scholar
• POUYANNE P, HARAMBURU F, IMBS JL, BEGAUD D: Admissions to hospital caused by adverse drug reactions: Cross sectional incidence study. Br. Med. J. (2000) 320(7241):1036.
   PubMed Web of Science ®Google Scholar
• CLASSEN DC, PESTOTNIK SL, EVANS RS, BURKE JP: Computarized surveillance of adverse drug events in hospital patients. J. Am. Med. Assoc. (1991) 266(20):2847–2851.
   PubMed Web of Science ®Google Scholar
• BATES DW, CULLEN DJ, LAIRD N: Incidence of adverse drug events and potential adverse drug events. J. Am. Med. Assoc. (1995) 274(1):29–34.
   PubMed Web of Science ®Google Scholar
• IMPICCIATORE P, CHOONARA I, CLARKSON A, PROVASI D, PANDOLFINI C, BONATI M: Incidence of adverse drug reactions in paediatric in/outpatients: A systematic review and meta-analysis of prospective studies. BE I Clin. Pharmacol (2001) 52(1):77–83.
   PubMed Web of Science ®Google Scholar
• DEMOLY P, BOUSQUET J: Epidemiology of drug allergy. Curr. Opin. Allergy Clin. Immunol (2001) 1(4):305–310.
   PubMed Web of Science ®Google Scholar
• JOHANSSON SGO, BIEBER T, DAHL R, FRIEDMANN PS et al.: Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol (2004) 113(5):832–836.
   PubMed Web of Science ®Google Scholar
• ••Important paper on the most updatednomenclature on hypersensitivity reactions for correct utilisation of terms.
   Google Scholar
• PICHLER WJ: Delayed drug hypersensitivity reactions. Ann. Intern. Med. (2003) 139(8):683–693.
   PubMed Web of Science ®Google Scholar
• •Detailed description of pathogenetic pathways of allergic hypersensitivity.
   Google Scholar
• RING J: Immunomodulation and the treatment of hives and eczema. World Allergy Forum Symposium: IgE and IgE receptors in allergic skin diseases. 61st AAAAI Annual Meeting, San Antonio, Texas, March 18, 2005.
   Google Scholar
• STERN RS, BIGBY M: An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. I Am. Med. Assoc. (1984) 252(11):1433–1437.
   PubMed Web of Science ®Google Scholar
• GOMES E, CARDOSO ME PRACA F, GOMES L, MARINO E, DEMOLY P: Self-reported drug allergy in a general adult portuguese population. Clin. Exp. Allergy (2004) 34(10):1597–1601.
   PubMed Web of Science ®Google Scholar
• SETTIPANE GA. Aspirin and allergic diseases. Am. J. Med. (1983) 74(6A):102–109.
   Google Scholar
• STROM BL, CARSON JL, LEE MORSE M: The effect of indication on hypersensitivity reactions associated with zomepirac sodium and other nonsteroidal anti-inflammatory drugs. Arthritis Rheum. (1987) 30(10):1142–1148.
   PubMed Web of Science ®Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A: Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann. Allergy Asthma Immunol (2000) 84(1):101–106.
   PubMed Web of Science ®Google Scholar
• STEVENSON DD: Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: Diagnosis and treatment. Allergy Asthma Proc. (2000) 21(1):25–31.
   PubMed Web of Science ®Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: NSAID-induced urticaria and angioedema. A reappraisal of its clinical management. Am. I Cirri. Dermatol (2002) 3(9):599–607.
   PubMedGoogle Scholar
• •General review of urticaria and angioedema triggered by NSAIDs.
   Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: Cutaneous reactions to aspirin and nonsteroidal anti-inflammatory drugs. Clin. Rev Allergy Immunol (2003) 24(2):125–136.
   PubMedGoogle Scholar
• •Comprehensive review of cutaneous adverse reactions to NSAIDs.
   Google Scholar
• KWOH CK, FEINSTEIN AR: Rates of sensitivity reactions to aspirin: Problems in interpreting the data. Clin. Pharmacol Ther. (1986) 40(5):494–505.
   PubMed Web of Science ®Google Scholar
• SZCZEKLIK A: The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. (1990) 3(5):588–593.
   PubMed Web of Science ®Google Scholar
• •Classic description of the mechanisms of aspirin-induced asthma and urticaria.
   Google Scholar
• MASTALERZ L, SETKOWICZ M, SANAK M, SZCZEKLIK A: Hypersensitivity to aspirin: Common eicosanoid alterations in urticaria and asthma. I Allergy Clin. Immunol (2004) 113(4):771–775.
   PubMed Web of Science ®Google Scholar
• •Demonstration of the COX theory in patients with chronic urticaria exacerbated by NSAIDs.
   Google Scholar
• QUIRALTE J, BLANCO C, CASTILLO R: Intolerante to nonsteroidal antiinflammatory drugs: results of controlled challenges in 98 patients. Allergy Clin. Immunol (1996) 98(3):678–685.
   Google Scholar
• ASERO R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J. Allergy Immunol (2003) 111(5):1095–1098.
   PubMed Web of Science ®Google Scholar
• ASERO R, TEDESCHI A, LORINI M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann. Allergy Asthma Immunol (2002) 88(5):468–472.
   PubMed Web of Science ®Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: The multiple faces of nonsteroidal anti-inflammatory drug hypersensitivity. Invest. Allergol Clin. Immunol (2004) 14(4):329–334.
   PubMed Web of Science ®Google Scholar
• •A practical approach to common hypersensitivity manifestations Induced by NSAIDs.
   Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: How safe are COX-2 inhibitors in NSAID-sensitive subjects with cutaneous reactions? Allergy Clin. Immunol Int. (2003) 15(3):110–113.
   Google Scholar
• SANCHEZ-BORGES M, CAPRILES-HULETT A, CABALLERO-FONSECA F: Adverse reactions to selective cyclooxygenase inhibitors (COXIBS). Am. J. Therap. (2004) 11(6):494–500.
   PubMedGoogle Scholar
• •Review article on cutaneous reactions to specific COX-2 inhibitors.
   Google Scholar
• NETTIS E, MARCANDREA M, FERRANNINI A, TURSI A: Tolerability of nimesulide and paracetamol in patients with NSAID-induced urticaria/ angioedema. Immunopharmacol Immunotoxicol (2001) 23(3):343–354.
   PubMed Web of Science ®Google Scholar
• ISPANO M, FONTANA A, SCIBILIA J, ORTOLANI C: Oral challenge with alternative nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol in patients intolerant to these agents. Drugs (1993) 46\(Suppl. 1):253–256.
   Google Scholar
• PEREZ C, SANCHEZ-BORGES M, CAPRILES-HULETT A: Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. I Allergy Clin. Immunol (2001) 108(6):1060–1061.
   PubMed Web of Science ®Google Scholar
• VAN DER KLAUW MM, WILSON JH, STRICKER BH: Drug-associated anaphylaxis: 20 years of reporting in the Netherlands (1974-1994) and review of the literature. Clin. Exp. Allergy(1996) 26(12):1341–1342.
   PubMedGoogle Scholar
• STROM BL, CARSON JL, SCHINNAR R, SIM E, LEE MORSE M: The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium versus other nonsteroidal anti-inflammatory drugs. I Rheumatol. (1988) 15(4):695–699.
   Web of Science ®Google Scholar
• TAKAHAMA H, KUBOTA Y, MIZOGUCHI M: A case of anaphylaxis due to ibuprofen. J. Dermatol. (2000) 27(5):337–340.
   PubMedGoogle Scholar
• MENENDEZ R, VENZOR J, ORTIZ G: Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Ann. Allergy Asthma Immunol (1998) 80(3):225–226.
   PubMed Web of Science ®Google Scholar
• CLENIN GE, VAN ROOIJEN MM, BRAATHEN LR: Ibuprofen-induzierte, transient ANA- und anti-histon positive leukozytoklastische vaskulitis. Der Hautarzt (2000) 51(9):678–681.
   PubMedGoogle Scholar
• PETERS F, MAESSEN-VISCH B, KHO L: Leukocytoclastic vasculitis induced by a nonsteroidal antiinflammatory. Rheumatol (1996) 23(10:2008–2009.
   Google Scholar
• DAVIDSON KA, RINGPFEIL F, LEE JB: Ibuprofen-induced bullous leukocytoclastic vasculitis. Culls (2001) 67(4):303–307.
   Google Scholar
• SRIVASTAVA M, PEREZ-ATAYDE A, JONAS MM: Drug-associated acute-onset vanishing bile duct and Stevens-Johnson's syndromes in a child. Gastroenterology (1998) 115(3):743–746.
   PubMed Web of Science ®Google Scholar
• BERGNER T, PRZYBILLA B: Photosensitization caused by ibuprofen. J. Am. Acad. Dermatol (1992) 26(1):114–116.
   PubMed Web of Science ®Google Scholar
• KANWAR AJ, BELHAJ MS, BHARIJA SC, MOHAMMED M: Drugs causing fixed eruptions. Dermatol (1984) 11(4):383–385.
   Google Scholar
• MAHBOOB A, HAROON TS: Drugs causing fixed eruptions: A study of 450 cases. Int. J. Dermatol (1998) 37(11):833–838.
   PubMed Web of Science ®Google Scholar
• KANWAR AJ, BHARIJA SC, SINGH M, BELHAJ MS: Ninety-eight fixed drug eruptions with provocation tests. Dermatologica (1988) 177(5):274–279.
   PubMedGoogle Scholar
• KULIGOWSKI ME, CHANG A, RATH R: Multiple fixed drug eruption due to ibuprofen. Contact Dermatitis (1991) 25(4):259–260.
   PubMed Web of Science ®Google Scholar
• CORAZZA M, CAPOZZI 0, VIRGILI A: Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs. J. Eur. Acad. Dermatol Venereol (2001) 15(6):585.
   PubMed Web of Science ®Google Scholar
• ALFONSO R, BELINCHON I: Linear drug eruption. Eur. j Dermatol (2001) 11(2):122–123.
   PubMed Web of Science ®Google Scholar
• KRASOWSKA D, SCHWARTZ RA, LECEWICZ-JORUN B: Generalized lichenoid drug eruption following Blaschko lines. Int. J. Dermatol (2001) 40(12):774.
   PubMed Web of Science ®Google Scholar
• YESUDIAN PD, PENNY M, AZURDIA RM, KING CM: Ibuprofen-induced acute generalized exanthematous pustulosis. bit. J. Dermatol (2004) 43(3):208.
   Web of Science ®Google Scholar
• ROUJEAU JC, Bioulac-SAGE P, BOURSEA C et al.: Acute generalized exanthematous pustulosis. Arch. Dermatol. (1991) 127(9):1333–1338.
   PubMed Web of Science ®Google Scholar
• GRATTAN LE: Generalized eruptive pustular drug rash due to naproxen. Dermatologica (1989) 179(1):57–58.
   PubMedGoogle Scholar
• NETTIS E, GIORDANO D, COLANARDI MC, PARADISO MT, FERRANNINI A, TURSI A: Delayed-type hypersensitivity rash from ibuprofen. Allergy (2003) 58(6):539–540.
   PubMed Web of Science ®Google Scholar
• CIVATTE J: Drug-induced pemphigus diseases. Dermatol Monatsschr. (1989) 175(1): 1–7 .
   PubMedGoogle Scholar
• FELLNER MJ: Drug-induced bullous pemphigoid. Clin. Dermatol (1993) 11(4):515–520.
   PubMed Web of Science ®Google Scholar
• VERONESI S, DE PADOVA MP, BARDAZZI F, MELINO M: Contact dermatitis to ibuprofen. Contact Dermatitis (1986) 15(2):103–104.
   PubMed Web of Science ®Google Scholar
• VALSECCHI R, CAINELLI T: Contact dermatitis from ibuproxam. A case with cross-reactivity with ketoprofen. Contact Dermatitis (1990) 22(1):51.
   PubMed Web of Science ®Google Scholar
• SANCHEZ-BORGES M, CAPRILES-BEHRENS E, CABALLERO-FONSECA F: Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood. Pediatr. Allergy Immunol (2004) 15(4):376–380.
   PubMed Web of Science ®Google Scholar
• •A recent review on a subject needing more research.
   Google Scholar
• SETTIPANE RA, CONSTANTINE HP, SETTIPANE GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy (1980) 35(2):149–154.
   Google Scholar
• LESKO SM, MITCHELL AM: An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. J. Am. Med. Assoc. (1995) 273(12):929–933.
   PubMed Web of Science ®Google Scholar
• LESKO SM, MITCHELL AM: The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics (1999) 104(4):e39.
   PubMedGoogle Scholar
• CAPRILES-BEHRENS E, CAPLIN J, SANCHEZ-BORGES M: NSAID facial angioedema in a selected pediatric atopic population. I Inv. Allergol Immunol (2000) 10(5):277–279.
   Web of Science ®Google Scholar
• DIAZ JARA M, PEREZ A, GRACIA MT, CABRERIZO S, ZAPATERO L, MARTINEZ MI: Allergic reactions due to ibuprofen in children. Pediatr. Dermatol (2001) 18(0:66–67.
   PubMedGoogle Scholar